| Literature DB >> 29713133 |
Carlos Kiyoshi Furuya1, Paulo Sakai2, Fabio Ramalho Tavares Marinho2, Jose Pinhata Otoch3, Spencer Cheng2, Lívia Lemes Prudencio3, Eduardo Guimarães Hourneaux de Moura2, Everson Luiz de Almeida Artifon4.
Abstract
AIM: To compare the cannulation success, biochemical profile, and complications of the papillary fistulotomy technique vs catheter and guidewire standard access.Entities:
Keywords: Catheterization; Common bile duct; Complications; Endoscopic retrograde cholangiopancreatography; Therapeutic use
Mesh:
Substances:
Year: 2018 PMID: 29713133 PMCID: PMC5922998 DOI: 10.3748/wjg.v24.i16.1803
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
Figure 1Schematic sequence of papillary fistulotomy. A and B: Dissection of the major papilla; C: Sphincterotome in the bile duct; D: Radiological image.
Figure 2Sequence of papillary fistulotomy. A and B: Dissection of the major papilla; D: Sphincterotome in the bile duct; D: Radiological image.
Patient characteristics and baseline laboratory tests
| Age in yr | 0.343 | |||
| Mean ± σ | 57.4 ± 19.3 | 60.9 ± 18.1 | 59.1 ± 18.7 | |
| Median (min; max) | 56 (19; 91) | 64 (22; 95) | 58 (19; 95) | |
| Sex, | > 0.999 | |||
| Female | 33 (64.7) | 33 (64.7) | 66 (64.7) | |
| Male | 18 (35.3) | 18 (35.3) | 36 (35.3) | |
| AST | 0.680 | |||
| Mean ± σ | 116.3 ± 143.4 | 124.3 ± 168.3 | 120.1 ± 155.1 | |
| Median (min; max) | 44 (8; 691) | 60 (13; 762) | 50 (8; 762) | |
| ALT | 0.873 | |||
| Mean ± σ | 163.6 ± 191.6 | 154.1 ± 169.3 | 159 ± 180.4 | |
| Median (min; max) | 83 (9; 776) | 104 (11; 662) | 90 (9; 776) | |
| AP | 0.585 | |||
| Mean ± σ | 267.8 ± 329.7 | 301.9 ± 320.4 | 284.3 ± 323.9 | |
| Median (min; max) | 153.5 (8; 1567) | 173 (32; 1320) | 162 (8; 1567) | |
| GGT | 0.821 | |||
| Mean ± σ | 532 ± 454.3 | 543.4 ± 578.2 | 537.5 ± 515.1 | |
| Median (min; max) | 466.5 (39; 1684) | 284 (11; 2269) | 382 (11; 2269) | |
| Total bilirubin | 0.994 | |||
| Mean ± σ | 4.1 ± 4.9 | 5.3 ± 7.5 | 4.7 ± 6.3 | |
| Median (min; max) | 2 (0.1; 23.4) | 2.1 (0.2; 29.2) | 2.1 (0.1; 29.2) | |
| Direct bilirubin | 0.683 | |||
| Mean ± σ | 3.6 ± 4.4 | 4.2 ± 6.3 | 3.9 ± 5.4 | |
| Median (min; max) | 1.6 (0.1; 20.9) | 1.1 (0.1; 22.4) | 1.5 (0.1; 22.4) |
Student’s t-test;
Chi-square test, Mann-Whitney test. AST: Aspartate transaminase; ALT: Alanine transaminase; AP: Alkaline phosphatase; GGT: Gamma-glutamyl transpeptidase; σ: Standard deviation.
Endoscopic retrograde cholangiopancreatography findings and complications n (%)
| Choledocolithiasis | 0.048 | |||
| No | 10 (19.6) | 19 (37.3) | 29 (28.4) | |
| Yes | 41 (80.4) | 32 (62.7) | 73 (71.6) | |
| Intrahepatic dilatation | 0.6572 | |||
| No | 36 (70.6) | 38 (74.5) | 74 (72.6) | |
| Yes | 15 (29.4) | 13 (25.5) | 28 (27.4) | |
| Extrahepatic dilatation | 0.5512 | |||
| No | 25 (49.02) | 22 (43.1) | 47 (46.1) | |
| Pancreatitis | 2 (3.9) | 1 (1.9)) | 3 (2.9) | 1 |
| Yes | 26 (50.98) | 29 (56.9) | 55 (53.9) | |
| Pancreatitis | 3 | 0 | 3 (2.9) | 0.0991 |
| Intra- or peridiverticular papilla | 0.046 | |||
| No | 43 (84.3) | 49 (96.1) | 92 (90.2) | |
| Yes | 8 (15.7) | 2 (3.9) | 10 (9.8) | |
| Prosthesis | 0.236 | |||
| No | 42 (82.4) | 37 (72.6) | 79 (77.5) | |
| Yes | 9 (17.6) | 14 (27.4) | 23 (22.5) | |
| Biliary prosthesis | 0.463 | |||
| No | 42 (82.4) | 39 (76.5) | 81(79.4) | |
| Yes | 9 (17.6) | 12 (23.5) | 21 (20.6) | |
| Cholangitis | 0.678 | |||
| No | 49 (96.1) | 47 (92.2) | 96 (94.1) | |
| Yes | 2 (3.9) | 4 (7.9) | 6 (5.9) | |
| Biliary access | ||||
| No | 12 (23.5) | 0 | 0.0002 | |
| Yes | 39 (76.5) | 51 (100) | ||
| Complications,pancreatitis, bleeding or perforation | 0.0537 | |||
| No | 44 (86.3) | 50 (98) | 94 (92.2) | |
| Yes | 7 (13.7) | 1 (2) | 8 (7.8) | |
| Pancreatitis | 5 | 1 | ||
| Perforation | 2 | 1 | ||
| Bleeding | 0 | 0 |
Data are presented as n (%).
Fisher’s exact test; Chi-square test.
Figure 3Flowchart showing the sequence of procedures performed in the study.
Endoscopic retrograde cholangiopancreatography findings and complications according to group and subgroup
| Complications, pancreatitis, bleeding or perforation | 0.062 | ||||
| No | 34 (87.2) | 10 (83.3) | 50 (98) | 94 (92.2) | |
| Yes | 5 (12.8) | 2 (16.7) | 1 (2) | 8 (7.8) | |
| Number of cannulations | < 0.001 | ||||
| Mean ± σ | 3.3 ± 1.9 | 7.5 ± 2.8 | 4.3 ± 2.8 | ||
| Median (min.; max.) | 3 (1; 10) | 8.5 (3; 10) | 3 (1; 10) | ||
Mann-Whitney test, Likelihood ratio test. GWC: Guidewire cannulation; σ: Standard deviation.
Lipase, amylase and C-reactive protein measurements at the different evaluation times
| Lipase | 0.006 | < 0.001 | 0.026 | ||||||
| mean ± σ | 69.4 ± 102.1 | 439.0 ± 1064.8 | 199.5 ± 528.3 | 41.4 ± 37.2 | 100.6 ± 183.3 | 85.2 ± 189.1 | |||
| median (min; max) | 38 (9; 611) | 52 (10; 5014) | 48 (8; 3000) | 32 (0; 239) | 42.5 (8; 968) | 40 (5; 1334) | |||
| Amylase | 0.003 | < 0.001 | 0.013 | ||||||
| mean ± σ | 76.4 ± 57.8 | 453.5 ± 1287.4 | 304.0 ± 979.3 | 59.6 ± 36.2 | 98.1 ± 94.3 | 85.8 ± 102.6 | |||
| median (min; max) | 59 (12; 310) | 80 (14; 7900) | 70 (13; 6721) | 50 (14; 236) | 69 (21; 624) | 67.5 (12; 732) | |||
| C-reactive protein | 0.189 | 0.070 | 0.353 | ||||||
| mean ± σ | 126.6 ± 539.7 | 49.5 ± 89.7 | 45.4 ± 70.5 | 58.6 ± 104.8 | 41.4 ± 62.0 | 38.8 ± 52.9 | |||
| median (min; max) | 11.1 (0.1; 3813) | 15.5 (0.3; 486.1) | 19.16 (0.5; 340.9) | 12 (0.2; 549) | 13.8 (0.3; 271) | 16.6 (0.5; 223.1) | |||
GEE with gamma distribution and identity link function. Not all patients were evaluated at all times. GEE: Generalized estimating equations; σ: Standard deviation.
Figure 4Amylase profile after the procedure.
Figure 5Lipase profile for the two groups.
Figure 6Evolution of C-reactive protein.